Simona Littnerova
Overview
Explore the profile of Simona Littnerova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
334
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kotherova S, Cigan J, Stepankova L, Vyskocilova M, Littnerova S, Ejova A, et al.
J Relig Health
. 2024 Apr;
63(6):4840-4860.
PMID: 38605255
Buddhist meditation practices, including Samadhi meditation, which forms the basis for mindfulness practice, are broadly promoted as pathways to wellbeing, but evidence of their adverse effects is emerging. In a...
2.
Medilek K, Bis J, Polansky P, Kvasnicka T, Borg A, Dusek J, et al.
Echocardiography
. 2023 Jul;
40(8):784-791.
PMID: 37417924
Aims: Transcatheter aortic valve replacement (TAVR) has become the standard of care for selected patients with severe aortic stenosis. Multidetector computed tomography (MDCT) and transoesophageal 2D/3D (two-dimensional/three-dimensional) echocardiography (ECHO) are...
3.
Sedova P, Kent J, Bryndziar T, Jarkovsky J, Tomek A, Sramek M, et al.
Eur J Neurol
. 2022 Dec;
30(4):943-950.
PMID: 36511840
Background And Purpose: During the coronavirus disease 2019 (COVID-19) pandemic many countries reported a decline in stroke volumes. The aim of this study was to analyze if the decline was...
4.
Majek O, Gregor J, Mogulkoc N, Lewandowska K, Sterclova M, Muller V, et al.
PLoS One
. 2022 Sep;
17(9):e0273854.
PMID: 36048805
Background: There is no clear evidence whether pirfenidone has a benefit in patients with probable or possible UIP, i.e. when idiopathic pulmonary fibrosis (IPF) is diagnosed with a lower degree...
5.
Jovanovic D, Sterclova M, Mogulkoc N, Lewandowska K, Muller V, Hajkova M, et al.
Respir Res
. 2022 May;
23(1):135.
PMID: 35624513
Background: Patients with idiopathic pulmonary fibrosis (IPF) frequently have multiple comorbidities, which may influence survival but go under-recognised in clinical practice. We therefore report comorbidity, antifibrotic treatment use and survival...
6.
Kolonics-Farkas A, Sterclova M, Mogulkoc N, Lewandowska K, Muller V, Hajkova M, et al.
Front Med (Lausanne)
. 2022 Jan;
8:729203.
PMID: 35004713
Idiopathic pulmonary fibrosis (IPF) is a rare lung disease with poor prognosis. The diagnosis and treatment possibilities are dependent on the health systems of countries. Hence, comparison among countries is...
7.
Stanik M, Poprach A, Littnerova S, capak I, Hulova M, Sebova N, et al.
Urol Oncol
. 2021 Dec;
40(3):111.e27-111.e34.
PMID: 34961683
Aims: Isolated retroperitoneal recurrence (IRR) in renal cancer patients after radical nephrectomy (RN) is a rare event and poses a therapeutic dilemma. We evaluated oncologic outcomes in surgically treated patients...
8.
Doubkova M, Kriegova E, Littnerova S, Schneiderova P, Sterclova M, Bartos V, et al.
Ther Adv Respir Dis
. 2021 Sep;
15:17534666211042529.
PMID: 34515605
Background: The antifibrotic drugs nintedanib and pirfenidone are used for the treatment of idiopathic pulmonary fibrosis (IPF). We analysed the association of common profibrotic polymorphisms in (mucin 5B, rs35705950) and...
9.
Sedova P, Brown Jr R, Bryndziar T, Jarkovsky J, Tomek A, Sramek M, et al.
Cerebrovasc Dis
. 2021 Sep;
51(1):52-59.
PMID: 34515067
Introduction: During the COVID-19 pandemic, studies reported less number of hospitalizations for acute stroke and reduction in the use of recanalization treatments. This study analyzes nationwide data on stroke admissions...
10.
Kolonics-Farkas A, Sterclova M, Mogulkoc N, Kus J, Hajkova M, Muller V, et al.
Drug Saf
. 2020 Aug;
43(10):971-980.
PMID: 32734423
Introduction: Nintedanib, a tyrosine kinase receptor inhibitor, may be associated with increased bleeding risk. Thus, patients with an inherited predisposition to bleeding, or those receiving therapeutic doses of anticoagulants or...